Interestingly, a similar result was reported in the Israeli study [13], where BRCA1/2 mutation carriers, a large majority of them already diagnosed with breast cancer, demonstrated only in 24.8% low FMR1 alleles, while random controls demonstrated low FMR1 alleles in 31.5% of women. Here, BRCA1 is linked to breast cancer.